A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions
Clinical trial NCT04645797 · TERMINATED
Trial details
- NCT number
- NCT04645797
- Sponsor
- Apros Therapeutics, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-19
- Primary completion
- 2022-05-07
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.